News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Matthew Katz: Consensus-based OAR dose constraint and target goal templates for lung cancer radiation therapy
Matthew Katz/LinkedIn
Dec 3, 2024, 19:22

Matthew Katz: Consensus-based OAR dose constraint and target goal templates for lung cancer radiation therapy

Matthew Katz, Radiation Oncologist at Tufts Medical Center, shared a post on X about a paper by Julius Weng et al. published in Practical Radiation Oncology:

“Our Delphi consensus-based approach included 83 thoracic radiation oncologists in at least one survey to create consensus-based OAR dose constraint and target goal templates for lung cancer radiation therapy.

What do you think? What comes next?”

“Dose Planning and Radiation Optimization for Thoracic Conventional, Twice Daily, and Stereotactic Radiation Therapy: A Delphi Consensus from a National Survey of Practitioners”

Authors: Julius Weng, Jeff Ryckman, Matthew Katz, Hina Saeed, Christopher Estes, Issam El Naqa, Amy Moreno, Sue Yom.

Matthew Katz: Consensus-based OAR dose constraint and target goal templates for lung cancer radiation therapy

More posts featuring Matthew Katz.

Amy Moreno cancer Christopher Estes Delphi consensus Hina Saeed Issam El Naqa Jeff Ryckman Julius Weng Lung cancer Matthew Katz OncoDaily Oncology Sue Yom
Special Coverage
Blog
Aug 3, 2025, 10:08
Arutha Kulasinghe: A Non-Invasive Approach to Monitor Dynamic Changes in Tumour and Immune Signatures in NSCLC
Blog
Aug 3, 2025, 09:53
Asfand Yar Cheema: Important Guidance for Visiting Medical Students and Graduates in the U.S.
Blog
Aug 3, 2025, 09:48
David Poplack Has Recieved the 2025 Lifetime Achievement Award - SIOP
Science
Aug 3, 2025, 09:37
Karin Tollefson: Ensuring the Right Care for Those with ALK+ Lung Cancer
Career
Aug 3, 2025, 09:36
Lazar Popovic Started a New Position as a Head of Clinic for Medical Oncology at Oncology Institute of Vojvodina
Blog
Aug 3, 2025, 09:25
Jia (Jenny) Liu: The First Early Phase Trials I Have Had the Privilege of Conducting as PI
Blog
Aug 3, 2025, 08:39
Florian Lordick: How Do Early Survivors of Cancer Feel
Science
Aug 3, 2025, 07:02
Arndt Vogel: New Insights Into Metachronous Colorectal Cancer Risk in Lynch Syndrome
Science
Aug 3, 2025, 06:55
Elisabetta Bonzano: Prosigna Assay Influences Neoadjuvant Treatment Decisions in Early HR+/HER2- Breast Cancer
Insight
Aug 3, 2025, 06:23
Marilyn Heine: Pharmacy Benefit Manager Market Concentration and Its Impact
Drugs
Aug 3, 2025, 05:58
Nirogacestat (Ogsiveo) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Blog
Aug 3, 2025, 05:48
Estela Rodriguez: Topics I Wish I Heard Early in My Career Covering at the WCLC25 IASLC Workshop